logo

BTMD

biote
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

BTMD fundamentals

biote (BTMD) released its earnings on May 7, 2025: revenue was 48.99M (YoY +4.68%), beat estimates; EPS was 0.37 (YoY +716.67%), beat estimates.
Revenue / YoY
48.99M
+4.68%
EPS / YoY
0.37
+716.67%
Report date
May 7, 2025
BTMD Earnings Call Summary for Q1,2025
  • Topline Growth: Q1 revenue up 4.7% to $49M, driven by 25.5% dietary supplement surge
  • Margin Expansion: Gross margin +300bps to 74.3% from manufacturing vertical integration
  • Strategic Restructuring: +25% field sales team expansion to accelerate new clinic growth
  • Challenges: Procedure revenue down 3.6% due to CDSS rollout disruption
  • 2025 Outlook: $202M-$208M revenue guidance, 2%–4% procedure growth target
  • Key Risk: Ongoing price competition in procedure business
EPS
Revenue

Revenue & Expenses

BTMD has released its 2025 Q1 earnings report, with revenue of 48.99M, reflecting a YoY change of 4.67%, and net profit of 15.84M, showing a YoY change of 376.62%. The Sankey diagram below clearly presents BTMD's revenue sources and cost distribution.

Key Indicators

biote (BTMD) key financial stats and ratios, covering profitability, financial health, and leverage.
biote (BTMD)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
biote (BTMD)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
biote (BTMD)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does biote (BTMD) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track biote (BTMD) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield